Glenn Michael Preminger
· James F. Glenn, M.D. Distinguished Professor of UrologyVerifiedDuke University · Urology
Active 1980–2026
About
Glenn Michael Preminger is a Distinguished Professor of Urology and a Professor of Urology at Duke University. He is associated with the Duke Department of Urology, located at 30 Duke Medicine Circle, Durham, NC. His roles include participating in the Urology Residency Program and the Duke Endourology and Metabolic Stone Disease Fellowship. His work is focused on urology, with a particular emphasis on endourology and metabolic stone disease, contributing to education and training within the department.
Research topics
- Medicine
- Surgery
- Optics
- Materials science
- Internal medicine
- Radiology
- General surgery
- Urology
- Biomedical engineering
- Composite material
- Artificial Intelligence
- Algorithm
- Geometry
- Acoustics
- Family medicine
- Physics
- Cardiology
- Psychiatry
- Anesthesia
- Astrobiology
- Mathematics
Selected publications
Journal of Endourology · 2026-02-11
articlePurpose: The ASPiration to Improve Renal Calculi Removal Effectiveness study showed steerable ureteroscopic renal evacuation (SURE) with CVAC that significantly reduced residual stone volume at 30 days vs standard ureteroscopy (URS). This report presents 2-year health care consumption and stone events (SE) and their link to residual stone volume and other variables ( n = 101 at primary end point; n = 93 at 2 years). Materials and Methods: Logistic regression identified predictors of health care consumption events (HCEs), that is, emergency department visits, hospitalization, surgical retreatment, and SE across the study population. Incidence was compared between the treatment groups with Kaplan–Meier survival analysis. Results: At 2 years, residual stone volume was significantly associated with both HCEs and SE. For every 100 mm 3 increase in residual stone volume, the HCE risk increased by 50% to 54%, and the SE risk increased by 70%. Stone-free rate, the number of residual fragments (RFs), and RF total stone burden (based on diameter) were not predictors. Significantly fewer HCEs occurred in the SURE group (3 vs 20 events, p = 0.0004). Survival analysis confirmed this (4.3% vs 20%, log-rank p = 0.02), with a 73% risk reduction (hazard ratio 0.27, 95% Cl 0.09–0.80, p = 0.02). Fewer SE occurred in the SURE group, although not statistically significant. These subjects also had longer event-free survival. Conclusion: High-quality volumetric analysis supports evaluation of stone removal therapies, as residual stone volume predicts HCEs and SE. SURE significantly reduces the downstream incidence and risk of HCEs compared with standard URS.
The Journal of Urology · 2026-04-27
articleHighlighting the 2025 AUA Nephrolithiasis Guidelines
The Journal of Urology · 2026-01-30
articleSenior authorThe Journal of Urology · 2026-04-27
articleWorld Journal of Urology · 2026-01-11 · 1 citations
articleOpen accessThe Journal of Urology · 2026-04-27
articleThe Journal of Urology · 2026-04-27
articleThe Journal of Urology · 2026-04-27
articleEuropean Urology Open Science · 2025-11-01
articleOpen accessMP33-08 ENHANCING UROLOGY REFERRAL INTAKE THROUGH AI-ASSISTED PRE-CHARTING: A PILOT STUDY
The Journal of Urology · 2025-04-08
article
Recent grants
NIH · $24.5M · 2009
NIH · $1.7M · 2008
Frequent coauthors
- 720 shared
David Albala
- 588 shared
Stephen Y. Nakada
- 561 shared
Ralph V. Clayman
- 540 shared
Elspeth M. McDougall
University of British Columbia
- 522 shared
Gerhard Fuchs
University of Southern California
- 494 shared
Jens Rassweiler
- 489 shared
Martin T. Grune
University of Nebraska Medical Center
- 486 shared
Raju Thomas
Education
- 1977
MD
New York Medical College
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Glenn Michael Preminger
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup